The CoaguChek® XS SystemThe next generation in POC anticoagulation testing from Roche Diagnostics

CLIA-Waived

The CoaguChek XS SystemExclusive smart technology helps ensure accurate results, and offers the flexibility and control that healthcare professionals need to confidently manage a wide range of anticoagulated patients.Accurate and flexible technology• Accurate, precise results in one minute• The only system to perform onboard quality control and determine patient results in a

single test chamber1, 2

• Neutralizes therapeutic levels of heparin and LMWH1

• INR corrected for hematocrit within specified range – manage a broad array of patients with one device1

Easy and convenient to use• Small sample size (8µl) for easy dosing• Strip allows dosing from either top or side for simple blood application• 18-month strip shelf life – no refrigeration needed• Outside meter blood application – minimizes potential for cross-contamination1

• Small, battery-powered, handheld meter for portability and efficiency

Efficient and cost-effective• Onboard controls – no external QC necessary• Auto-on with strip insertion and auto-off capabilities• Testing, treatment and potential revenue capture in one appointment3

• Fingerstick test that patients prefer4

The leader in point-of-care anticoagulation monitoringSince 1994, Roche Diagnostics has helped healthcare professionals provide quality care to their patients with a PT/INR meter they trust. Find out why more CoaguChek test strips are sold for point-of-care anticoagulation testing than all other brands combined.5 Contact your Roche representative to schedule an in-office demonstration.

Current Procedural Test (CPT) codes

Prothrombin time 85610CLIA-waived PT test 85610QW

Under Medicare Part B, CPT codes are used to identify medical tests and procedures including laboratory tests. Modifiers are added to a CPT code to provide additional information to Medicare. When an outpatient PT test is performed as a CLIA-waived test, by a CLIA-waived entity, the QW modifier must be added to the CPT code to obtain Medicare Part B reimbursement.

1 CoaguChekXSSystempackageinsert.Indianapolis,IN.RocheDiagnosticsCorporation,2006.2 INRatio®Systempackageinsert.Milpitas,CA.HemoSenseInc.,2003.ProTime®Systempackageinsert.Edison,NJ.ITC,2006.3 Campbell,P.,Radensky,P.,Denham,C.Economicanalysisofsystematicanticoagulationmanagementvs.routinemedicalcareforpatientsonoralwarfarin

therapy.Disease Management and Clinical Outcomes,December2000.4 FintelD.andHoffmanC.Thephysician’sguidetopreventingstrokesandloweringhealthrisksinpatientswithatrialfibrillation.NorthwestUniversityMedical

School,1997.5 Year-end2008dataasreportedinfirstquarter2009,totaldollarvolumeandshareofprojecteddistributorunitsalesoftheCoagulationReagents/Kits,POC

(91994)byGHXMarketIntelligenceData.TotalMarketincludesallmarketsectorsasdefinedbyGHXMI.Physician,LTC,TreatmentCenters,ClinicalLabora-tory,Hospital,HomeHealthcare,andOther/Unspecified.DataonfileatRocheDiagnostics.

COAGUCHEK is a trademark of Roche. All other trademarks are the property of their respective owners. © 2009 Roche Diagnostics. All rights reserved. 324-46222-1209

www.poc.roche.com Roche Diagnostics Corporation9115 Hague RoadIndianapolis, IN 46256